Results for
Pfizer
201 Results-
Pfizer, BioNTech propose EU pays half for each canceled COVID dose: Report
Pfizer Inc and BioNTech’s new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, ... World News -
Pfizer buys Seagen Inc. for $43 bln, boosts access to cancer drugs
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The ... Healthy Living -
US FDA approves nasal spray for migraines
The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said ... Healthy Living -
US FDA, CDC see early signal of Pfizer bivalent COVID-19 shot’s link to stroke
A safety monitoring system flagged that US drugmaker Pfizer Inc and German partner BioNTech’s updated COVID-19 shot could be linked to a type of brain ... Coronavirus -
US pharma firms Merck, Pfizer rebuff China’s push for price cuts on COVID-19 drugs
Top US makers of COVID-19 drugs appear to be pushing back on China’s efforts to get them to cut their prices, underscoring the challenges the country ... Coronavirus -
US FDA authorizes Moderna, Pfizer updated COVID-19 boosters for 6 months old children
The US Food and Drug Administration on Thursday authorized updated COVID-19 booster shots from Moderna and Pfizer and its partner BioNTech for ... World News -
Pfizer’s Paxlovid antiviral medication lowers long-COVID risk: Study
Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some ... Coronavirus -
US government to test Pfizer’s Paxlovid to treat long COVID
The US National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc’s antiviral drug Paxlovid as the first treatment it will ... World News -
Italy’s tax authorities investigate Pfizer profits: Sources
Italy’s tax authorities are investigating profits reported by Pfizer Inc’s local unit Pfizer Italia srl, two sources with knowledge of the matter told ... World News -
Pfizer COVID-19 vaccine clears Japan panel for use with young children
A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc’s COVID-19 vaccine for children as young as six months old.Japan in ... Coronavirus -
Booster jabs in GCC remain ‘critical’ to beat ‘unpredictable’ COVID-19: Pfizer chief
Residents in the GCC must continue to have regular booster jabs to combat the spread of the “highly unpredictable” and evolving COVID-19 virus, ... Coronavirus -
EU drug regulator backs omicron-adapted COVID-19 booster shots
The EU’s drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the omicron variant and developed by rivals ... Coronavirus -
Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine
Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the ... Coronavirus -
EU regulator launches review of Pfizer-BioNTech's adapted COVID-19 vaccine
The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, it said on ... World News -
Pfizer, BioNTech gain full FDA approval for COVID-19 vaccine for teens
Pfizer Inc. and BioNTech SE gained full US regulatory approval for their COVID-19 vaccine for teens 12 to 15 years old, a milestone that will allow ... Coronavirus -
Omicron-specific COVID-19 vaccines could increase protection as boosters: EMA
Coronavirus vaccines tweaked to include the omicron variant strain can improve protection when used as a booster, the European Medicines Agency and ... Coronavirus -
BioNTech, Pfizer to start testing universal vaccine for COVID-19
Germany’s BioNTech, Pfizer’s partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect ... Coronavirus -
Pfizer says omicron-fighting COVID-19 shots prompt strong immune response
Pfizer Inc.’s omicron-targeting vaccine and a hybrid shot that fights the original strain as well as omicron prompted strong immune responses in a ... Coronavirus -
US FDA opens way to COVID vaccines for children under five
The US Food and Drug Administration on Friday authorized two COVID-19 vaccines for children aged five and under, opening the door to vaccinating ... World News -
Moderna COVID-19 vaccine may pose higher heart inflammation risk: US CDC
Moderna’s COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech’s shot, the US Centers for Disease ... Coronavirus -
US: Pfizer COVID-19 shot appears effective for kids under five
Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under five, a key ... Coronavirus -
Pfizer to sell all its patented drugs at non-profit price in 45 low-income countries
Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not ... Healthy Living -
WHO clears China’s CanSino COVID-19 vaccine for emergency use
The World Health Organization said Thursday that it has granted an emergency use authorization for the coronavirus vaccine made by China’s CanSino ... Coronavirus -
Explainer: Some patients reporting COVID rebounds after taking Pfizer pills
More than 2.8 million courses of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United ... Coronavirus -
Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending more than $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already ... Financial Markets -
J&J suspends sales forecast for COVID-19 vaccine, cuts profit view
Johnson & Johnson on Tuesday cut its full-year profit expectation and suspended sales forecast for its COVID-19 vaccine after having earlier predicted ... Coronavirus -
Pfizer to expand COVID-19 booster shots to healthy five to 11-year-olds in US
Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.US health authorities already urge everyone 12 and ... Coronavirus -
Pfizer to buy lung-focused biotech developer ReViral for as much as $525 mln
Pfizer Inc. agreed to buy respiratory antiviral developer ReViral Ltd. for as much as $525 million, the COVID-19 vaccine maker’s latest move in the ... Business -
Current COVID-19 vaccines not ‘well-matched’ against BA.2: FDA
Current COVID-19 vaccines are not well-matched against the BA.2 sub-variant of omicron, the US Food and Drug Administration said on Wednesday, as its ... Coronavirus -
China approves Pfizer’s COVID pill Paxlovid for mild to moderate cases
China’s medical products regulator said on Saturday it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral ... World News